A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novartis AG gets positive opinion from CHMP for Fabhalta paroxysmal nocturnal hemoglobinuria treatment for adults; the therapy awaits final European Commission approval in the next two months, potentially becoming Europe's first oral monotherapy for PNH

Boehringer Ingelheim partners with Shanghai RAAS for the development and clinical production of hemophilia drug SR604 injection; the drug has received approval for Phase I clinical trial targeting hemophilia and congenital factor VII deficiency

Janssen Pharmaceutical targets innovative therapies for major diseases, aiming to transform patient care in AMD, multiple myeloma, and lung cancer

Bristol-Myers Squibb leads hematology innovation and expands neuroscience portfolio while advancing personalized CLL therapeutics

FDA advisory committee recommends early use of Janssen's new immunotherapy for relapsed/refractory multiple myeloma

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count